๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer

โœ Scribed by Janneta Tcherkassova; Carolina Abramovich; Rafael Moro; Chen Chen; Ralph Schmit; Angela Gerber; Ricardo Moro

Book ID
107693946
Publisher
S. Karger AG
Year
2011
Tongue
English
Weight
507 KB
Volume
32
Category
Article
ISSN
1010-4283

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combining a symptoms index with CA 125 t
Combining a symptoms index with CA 125 to improve detection of ovarian cancer
โœ M. Robyn Andersen; Barbara A. Goff; Kimberly A. Lowe; Nathalie Scholler; Lindsay ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND. The current study sought to examine whether an index based on the specific pattern of symptoms commonly reported by women with ovarian cancer could be used in combination with CA 125 to improve the sensitivity or specificity of experimental methods of screening for ovari

Elevated serum CA 125 levels prior to di
Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: Relevance for early detection of ovarian cancer
โœ Vincent R. Zurawski Jr.; Harald Orjaseter; Aage Andersen; Egil Jellum ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 472 KB ๐Ÿ‘ 1 views

To investigate the sensitivity of the C A 125 immunoradiometric assay for occult ovarian neoplasia, serum CA 125 levels were retrospectively determined "blind" in specimens collected from 105 women who subsequently developed ovarian neoplasia, and from 323 matched controls. The distribution of C A 1